HUMCO

Austin, United States Founded: 1872 • Age: 154 yrs Acquired By Fagron
Topical creams, syrups, suspensions, and APIs are manufactured.

About HUMCO

HUMCO is a Healthcare company based in Austin (United States) founded in 1872, and was acquired by Fagron in April 2018. Topical creams, syrups, suspensions, and APIs are manufactured. Its chief executive, as recorded, is Andrew Pulido. HUMCO offers products and services including OTC Medicines and Private Label Products. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides. Its competitors include Asymchem and Continuus Pharma; 1 of its 2 listed competitors has raised funding.

Company details

HUMCO was founded in 1872 in Austin, United States, and operates in the pharmaceutical sector. APIs and over-the-counter formulations are produced, including topical and transdermal creams, syrups, and suspensions across categories such as analgesics, anti-infectives, wound care, and dermatology. Drug delivery vehicles for gels, creams, and oral liquids are also manufactured.

  • Headquarters Austin, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website humco.com
  • Social LinkedIn X
  • Acquired by Fagron (Apr 2018)
Key Metrics

Products & Services of HUMCO

HUMCO offers a comprehensive portfolio of products and services, including OTC Medicines and Private Label Products.

OTC Medicines
Pharmaceuticals

High-quality over-the-counter medicines for consumer health needs

Private Label Products
Consumer Goods

Premium branded items supplied to retailers and wholesalers

Investors in HUMCO

HUMCO has secured backing from 1 investor. Prominent investors backing the company include Fagron.

All
InvestorDescriptionFounded YearDomainLocation
Drug compounding services are provided by Fagron.
1990fagron.comSaint Paul, United States
Premium access

Investor details for HUMCO

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of HUMCO

1 people are tracked at HUMCO (1 in leadership).

NameRoleGroup
Andrew Pulido
CEOLeadership
Premium access

Complete people profiles for HUMCO

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of HUMCO

2 dated milestones of HUMCO across 146 years, from founding to its latest funding, stage changes and deals.

  1. Founded HUMCO is founded.
  2. Exit Acquired by Fagron.

Competitors of HUMCO

HUMCO has 2 listed competitors in our database, 1 of them funded. They include Asymchem and Continuus Pharma.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
asymchem.com1995Morrisville, United States48
APIs and peptides are developed and manufactured by Asymchem.
continuuspharma.com2012Woburn, United States$7.73M47
MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development
Premium access

Detailed competitors of HUMCO

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of HUMCO

Websites that share an audience with HUMCO (humco.com).

Similar websites

Websites whose visitors overlap most with HUMCO. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
naturalcompounder.com
naturalcompounder.com
100%
#3,632,970–
healthunit.com
100%
#931,998View details
sombrausa.com
sombrausa.com
99%
#3,944,298–
bbpharmacy.com
bbpharmacy.com
71%
#6,844,607–

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as HUMCO (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Humco

Premium access

Complete news archive for HUMCO

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about HUMCO

HUMCO was founded in 1872.

HUMCO is headquartered in Austin, United States. It is registered at Austin, Texas, United States.

Andrew Pulido is the CEO of HUMCO, as recorded in our data.

HUMCO was founded in 1872 in Austin, United States, and operates in the pharmaceutical sector. APIs and over-the-counter formulations are produced, including topical and transdermal creams, syrups, and suspensions across categories such as analgesics, anti-infectives, wound care, and dermatology. Drug delivery vehicles for gels, creams, and oral liquids are also manufactured.

HUMCO's top competitors include Asymchem and Continuus Pharma.

HUMCO offers OTC Medicines and Private Label Products.

HUMCO has 1 investor. Key investors include Fagron.

Yes. HUMCO was acquired by Fagron in April 2018.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available